Dipexium Pharmaceut (DPRX) Misses Q3 EPS by 2c

Dipexium Pharmaceut (NASDAQ: DPRX) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c